Dr Ysobel Baker
Ysobel obtained her masters degree in Chemistry from the University of Southampton before moving to the University of Cambridge for her PhD studies, working at the chemistry/biology interface under the supervision of Prof. David Spring. She joined the Brown group in October 2015 investigating oligonucleotide functionalised nanoparticles with diagnostic and therapeutic applications and developing new artificual DNA backbone likkages. Yssy recently moved to the Nucleic Acid Therapeutics Accelerator MRC Unit at Harwell.
10 Papers
Synthesis, Affinity for Complementary RNA and DNA, and Enzymatic Stability of Triazole-Linked Locked Nucleic Acids (t-LNAs).
ACS Omega 3 (6), 6976-6987, 2018.
Preparation and characterization of manganese, cobalt and zinc DNA nanoflowers with tuneable morphology, DNA content and size
Nucleic Acids Res. 46 (15), 7495-7505, 2018.
Enzyme-free synthesis of cyclic single-stranded DNA constructs containing a single triazole, amide or phosphoramidate backbone linkage and their use as templates for rolling circle amplification and nanoflower formation
Chem. Sci. 9, 8110-8120, 2018.
Searching for the ideal triazole: Investigating the 1,5-triazole as a charge neutral DNA backbone mimic
Tetrahedron 76 (7), 130914, 2020.
Consecutive 5'- and 3'-amide linkages stabilise antisense oligonucleotides and elicit an efficient RNase H response
Chemical Communications 56, 5496-5499, 2020.
Expanding the chemical functionality of DNA nanomaterials generated by rolling circle amplification
Nucleic Acids Res. 49 (16), 9042-9052, 2021.
A New 1,5-Disubstituted Triazole DNA Backbone Mimic with Enhanced Polymerase Compatibility
Journal of the American Chemical Society 143 (39), 16293-16301, 2021.
Chemically modified nucleic acids and DNA intercalators as tools for nanoparticle assembly
Chemical Society Reviews 50, 13410-13440, 2021.
Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides
RSC Chemical Biology 3, 765-772, 2022.
An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides
Nature Communications 13 (1), 1-11, 2022.